Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics società ha sostenuto
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions leggi di più
Alignment to the key priorities, the four core programs.
Qual è la parte migliore del tuo compenso?
The salary is the best part of the compensation package.
Cosa ti piace di più del team di leadership?
The ET has the best interest of the company in mind, aligned with the key priorities.
Quali sono alcune delle cose migliori della tuo team?
They all have the best intentions, doing what they can to make Karyopharm a better place.
Other Employee Reviews for Karyopharm Therapeutics
×